LATE COMPLICATIONS AFTER THERAPY IN PATIENT WITH HODGKIN'S LYMPHOMA

During the past five decades, dramatic progress has been made in the development of curative therapy for hematologic malignancies, including Hodgkin's Lymphoma (HL). The therapy responsible for this survival can also produce adverse long-term health-related outcomes, referred to as «late effects», which manifest months to years after completion of cancer treatment. The purpose of this report is to pay attention to the problem of late complications, which develop in distant period after combined therapy of HL on example of illustrative clinical case.